This Remains a Bull Market for Stock-Pickers

There is some rotation in and out of hot sectors but there continues to be plenty of very positive action.

This Ulta Trade Is Right on Target

Look for ULTA to go to $300 or maybe higher.

Still Cautious on Stay-at-Home Stock Peloton's Rally

The background story of PTON seems positive, but the charts are not shouting 'jump back in.'

Cannabis Stocks Are Showing Signs of Life

I am watching names like Curaleaf and the MSOS cannabis ETF, which could keep moving higher.

Dialing Up a 'Deal' on the Dow

I want to own these calls on DIA this week.

Shark Bites: Buying the 'Sell the News' Reaction

I'm adding to my position in this SPAC today.

Unveiling My 2021 Double Net Value Portfolio

Eighteen stocks make the cut for the 2021 portfolio, which is comprised of seemingly cheap names relative to net current assets.

The Charts and Data Conflict: What Should Investors Do?

Chasing new purchases on certain stocks could prove hazardous.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

Just an Interruption, Not a Change in the Market's Character

Keep in mind the positive catalysts as we wrap up the year.